News - Gilde Healthcare

latest
news

Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Gilde Healthcare portfolio company Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it has acquired Syrinx Bioanalytics, a bioanalytical CRO based in Turku, Finland. The move is part of Synexa’s ongoing ‘buy and build’ growth strategy, aimed at building the global market leader in specialist biomarker and bioanalytical services. The two...
19. Mai 2022
Loading...
These were all messages
ebb22415da